biote Corp. (BTMD)
(Delayed Data from NSDQ)
$6.55 USD
-0.10 (-1.50%)
Updated Jun 18, 2024 04:00 PM ET
After-Market: $6.54 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BTMD 6.55 -0.10(-1.50%)
Will BTMD be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for BTMD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BTMD
Biote Corp. (BTMD) Q1 Earnings Beat Estimates
Agios Pharmaceuticals (AGIO) Reports Q1 Loss, Misses Revenue Estimates
BTMD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate QuidelOrtho (QDEL) to Report a Decline in Earnings: What to Look Out for
Aurora Cannabis (ACB) Moves 46.0% Higher: Will This Strength Last?
Earnings Preview: biote Corp. (BTMD) Q1 Earnings Expected to Decline
Other News for BTMD
Biote management to meet with Roth MKM
Biote management to meet with Roth MKM
Truist Financial Sticks to Their Buy Rating for biote (BTMD)
PTC Therapeutics, Oragenics, GT Biopharma among healthcare movers
Biote down 8% after J Capital publishes short report